clinical trial

April 21, 2017April 21, 2017

EpicGenetics, Universities Seek to Expand Fibromyalgia Genetic Markers Program, FM/a Test

News

EpicGenetics is collaborating with the University of California, Los Angeles (UCLA) and the University of Illinois College of Medicine Chicago (UIC) to gather genetic information from fibromyalgia patients to improve ... Read more

March 27, 2017March 27, 2017

Intec Pharma Launches Phase 1 Trial of Cannabinoid-based Therapy for Fibromyalgia, Lower Back Pain

News

Israel’s Intec Pharma has initiated a Phase 1 clinical trial evaluating AP-CBD/THC to treat several disorders including fibromyalgia and lower back pain. The Jerusalem-based company developed AP-CBD/THC using its Accordion Pill platform containing ... Read more

August 3, 2016August 3, 2016

Lyrica Trial for Adolescent Fibromyalgia Fails, but Offers Other Positive Findings

News

Two Phase 4 clinical trials of Lyrica (pregabalin) in adolescent fibromyalgia patients failed to statistically improve mean pain scores, but showed good effects on a number of other measurements, suggesting ... Read more

July 27, 2016July 27, 2016

2nd Phase 3 Study of Low-dose Oral Treatment for Fibromyalgia Gets Underway

News

Tonix Pharmaceuticals announced that the first patient has been dosed in RE-AFFIRM, the company’s second Phase 3 clinical trial evaluating its cyclobenzaprine HCl sublingual tablets, known as TNX-102 SL, as a low-dose nighttime treatment for fibromyalgia. TNX-102 SL ... Read more

June 20, 2016June 21, 2016

New Fibromyalgia Treatment Improves Pain, Sleep Disorder Symptoms

News

Test findings about a novel fibromyalgia drug from the pharmaceutical company Tonix were released at the recent European League Against Rheumatism (EULAR) Scientific Congress in London. The presentation, “TNX-102 SL for the Treatment ... Read more

May 6, 2016May 6, 2016

UK Research Team Launches Clinical Trial Aimed At Fibromyalgia And Chronic Widespread Pain Onset Prevention

News

A U.K. research group has launched what they say is the first ever randomized clinical trial conducted with the objective of preventing the onset of chronic widespread pain (CWP — ... Read more

May 4, 2016May 19, 2016

Tonix Pharmaceuticals Completes Enrollment in Fibromyalgia Phase 3 Clinical Trial

News

Tonix Pharmaceuticals, a company developing next-gen therapies for disorders of the central nervous system, including fibromyalgia and post-traumatic stress disorder (PTSD), has completed enrollment in its Phase 3 AFFIRM clinical trial of TNX-102 ... Read more

March 30, 2016May 19, 2016

Tonix to Present Programs for PTSD, Fibromyalgia Drug Candidate at European Conference

News

Tonix Pharmaceuticals, a company dedicated to developing next-gen medicines for fibromyalgia and post-traumatic stress disorder (PTSD), announced its Executive Vice President of Commercial Planning and Development, Ronald Notvest, Ph.D., MBA, will present at the ... Read more

March 9, 2016March 9, 2016

Pregabalin Appears to Lower Fibromyalgia Pain, Increase Quality Sleep

News

Recent findings suggest that pregabalin may help reduce pain and improve the quality of sleep in fibromyalgia patients. The study, “The safety and efficacy of pregabalin for treating subjects with ... Read more

February 8, 2016May 19, 2016

Tonix to Discuss Fibromyalgia Study Results at BIO CEO & Investor Meet

News

Tonix Pharmaceuticals Holding Corp., a company developing next-generation therapeutics for fibromyalgia, episodic tension-type headaches, and post-traumatic stress disorder (PTSD), is among the participants at the 18th annual BIO CEO & Investor ... Read more